The Evolution of Adenoviral Vectors through Genetic and Chemical Surface Modifications

被引：36

作者：

Capasso, Cristian ^{[1
]}

Garofalo, Mariangela ^{[2
]}

Hirvinen, Mari ^{[1
]}

Cerullo, Vincenzo ^{[1
]}

机构：

[1] Univ Helsinki, Fac Pharm, Div Pharmaceut Biosci & CDR, Lab Immunovirotherapy,Bioctr 2, Helsinki 00790, Finland

[2] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, I-80131 Naples, Italy

来源：

VIRUSES-BASEL | 2014年 / 6卷 / 02期

关键词：

gene therapy; adenoviral vectors; genetic modification; chimeric fibers; surface modification; pseudotyping; polymers; immunogenicity; re-targeting; INNATE IMMUNE-RESPONSE; POLYETHYLENE-GLYCOL MODIFICATION; COMPLEMENT REGULATORY PROTEINS; ONCOLYTIC ADENOVIRUS; RECOMBINANT ADENOVIRUS; IN-VIVO; VIRAL-ANTIGENS; FIBER SHAFT; INFLAMMATORY RESPONSE; REPLICATION-COMPETENT;

D O I：

10.3390/v6020832

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

A long time has passed since the first clinical trial with adenoviral (Ad) vectors. Despite being very promising, Ad vectors soon revealed their limitations in human clinical trials. The pre-existing immunity, the marked liver tropism and the high toxicity of first generation Ad (FG-Ad) vectors have been the main challenges for the development of new approaches. Significant effort toward the development of genetically and chemically modified adenoviral vectors has enabled researchers to create more sophisticated vectors for gene therapy, with an improved safety profile and a higher transduction ability of different tissues. In this review, we will describe the latest findings in the high-speed, evolving field of genetic and chemical modifications of adenoviral vectors, a field in which different disciplines, such as biomaterial research, virology and immunology, co-operate synergistically to create better gene therapy tools for modern challenges.

引用

页码：832 / 855

页数：24

共 139 条

[91] Multiple Innate Immune Pathways Contribute to the Immunogenicity of Recombinant Adenovirus Vaccine Vectors [J].

Rhee, Elizabeth G. ;

Blattman, Joseph N. ;

Kasturi, Sudhir P. ;

Kelley, R. Phelps ;

Kaufman, David R. ;

Lynch, Diana M. ;

La Porte, Annalena ;

Simmons, Nathaniel L. ;

Clark, Sarah L. ;

Pulendran, Bali ;

Greenberg, Philip D. ;

Barouch, Dan H. .

JOURNAL OF VIROLOGY, 2011, 85 (01) :315-323

[92] Short-Fiber Protein of Ad40 Confers Enteric Tropism and Protection Against Acidic Gastrointestinal Conditions [J].

Rodriguez, Ester ;

Romero, Carolina ;

Rio, Adolfo ;

Miralles, Marta ;

Raventos, Aida ;

Planells, Laura ;

Burgueno, Joan F. ;

Hamada, Hirofumi ;

Carlos Perales, Jose ;

Bosch, Assumpcio ;

Angel Gassull, Miguel ;

Fernandez, Ester ;

Chillon, Miguel .

HUMAN GENE THERAPY METHODS, 2013, 24 (04) :195-204

[93] Improved systemic antitumor therapy with oncolytic adenoviruses by replacing the fiber shaft HSG-binding domain with RGD [J].

Rojas, J. J. ;

Gimenez-Alejandre, M. ;

Gil-Hoyos, R. ;

Cascallo, M. ;

Alemany, R. .

GENE THERAPY, 2012, 19 (04) :453-457

[94] GENE-TRANSFER INTO HUMANS - IMMUNOTHERAPY OF PATIENTS WITH ADVANCED MELANOMA, USING TUMOR-INFILTRATING LYMPHOCYTES MODIFIED BY RETROVIRAL GENE TRANSDUCTION [J].

ROSENBERG, SA ;

AEBERSOLD, P ;

CORNETTA, K ;

KASID, A ;

MORGAN, RA ;

MOEN, R ;

KARSON, EM ;

LOTZE, MT ;

YANG, JC ;

TOPALIAN, SL ;

MERINO, MJ ;

CULVER, K ;

MILLER, AD ;

BLAESE, RM ;

ANDERSON, WF .

NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (09) :570-578

[95] Magnetic Nanoparticles Enhance Adenovirus Transduction In Vitro and In Vivo [J].

Sapet, Cedric ;

Pellegrino, Christophe ;

Laurent, Nicolas ;

Sicard, Flavie ;

Zelphati, Olivier .

PHARMACEUTICAL RESEARCH, 2012, 29 (05) :1203-1218

[96] Heterologous expression of adenovirus E3-gp19K in an E1a-deleted adenovirus vector inhibits MHC I expression in vitro, but does not prolong transgene expression in vivo [J].

Schowalter, DB ;

Tubb, JC ;

Liu, M ;

Wilson, CB ;

Kay, MA .

GENE THERAPY, 1997, 4 (04) :351-360

[97] Immune response to helper dependent adenoviral mediated liver gene therapy: Challenges and prospects [J].

Seiler, Michael P. ;

Cerullo, Vincenzo ;

Lee, Brendan .

CURRENT GENE THERAPY, 2007, 7 (05) :297-305

[98] Adenovirus capsid-display of the retro-oriented human complement inhibitor DAF reduces Ad vector-triggered immune responses in vitro and in vivo [J].

Seregin, Sergey S. ;

Aldhamen, Yasser A. ;

Appledorn, Daniel M. ;

Hartman, Zachary C. ;

Schuldt, Nathaniel J. ;

Scott, Jeannine ;

Godbehere, Sarah ;

Jiang, Haixiang ;

Frank, Michael M. ;

Amalfitano, Andrea .

BLOOD, 2010, 116 (10) :1669-1677

[99] Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity [J].

Shayakhmetov, DM ;

Gaggar, A ;

Ni, SH ;

Li, ZY ;

Lieber, A .

JOURNAL OF VIROLOGY, 2005, 79 (12) :7478-7491

[100]

Silva AC, 2010, CURR GENE THER, V10, P437

← 5 6 7 8 9 10 11 12 13 14 →